Finance

Lists
543064:BOM
Cohance Lifesciences Ltd
464,25 INR
+1,13%
(+5,20) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543064...
Open
460,25 INR
High
466,80 INR
Low
458,00 INR
Mkt. cap
177,79 მლრ.
Avg. vol.
72,19 ათ.
Volume
17,36 ათ.
P/E ratio
167,65
52-wk high
917,50 INR
52-wk low
267,85 INR
EPS
2,77 INR
No. of employees
3 ათ.
Open
460,25 INR
High
466,80 INR
Low
458,00 INR
Mkt. cap
177,79 მლრ.
Avg. vol.
72,19 ათ.
Volume
17,36 ათ.
P/E ratio
167,65
52-wk high
917,50 INR
52-wk low
267,85 INR
EPS
2,77 INR
No. of employees
3 ათ.
News stories
From web sources and news partners
Law360
Law360
·
23 წუთის წინ
Nasdaq Sued Over Delisting Of Social Media Co.
Simply Wall Street
Simply Wall Street
·
14 წუთის წინ
SK Hynix (NasdaqGS:SKHY) Stock Trades At A Discount After A 22% Fall
Seeking Alpha
Seeking Alpha
·
22 წუთის წინ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
MarketWatch
MarketWatch
·
4 საათის წინ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
About Cohance Lifesciences Ltd
CEO-
Employees2,81 ათ.
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitecohance.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,56 მლრდ.
5,45 მლრდ.
6,19 მლრდ.
4,22 მლრდ.
Cost of goods sold
1,41 მლრდ.
1,59 მლრდ.
3,56 მლრდ.
1,20 მლრდ.
Cost of revenue
1,41 მლრდ.
1,59 მლრდ.
3,56 მლრდ.
1,20 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,27 მლრდ.
1,19 მლრდ.
1,47 მლრდ.
1,33 მლრდ.
Operating expense
3,38 მლრდ.
3,37 მლრდ.
2,14 მლრდ.
3,50 მლრდ.
Total operating expenses
4,79 მლრდ.
4,96 მლრდ.
5,70 მლრდ.
4,71 მლრდ.
Operating income
769,30 მლნ.
484,10 მლნ.
491,10 მლნ.
-483,80 მლნ.
Other non operating income
156,00 მლნ.
61,60 მლნ.
-310,30 მლნ.
122,50 მლნ.
EBT including unusual items
837,70 მლნ.
406,00 მლნ.
199,10 მლნ.
-428,70 მლნ.
EBT excluding unusual items
837,70 მლნ.
454,60 მლნ.
171,40 მლნ.
-428,70 მლნ.
Income tax expense
173,80 მლნ.
115,80 მლნ.
116,00 მლნ.
23,20 მლნ.
Effective tax rate
20,75%
28,52%
58,26%
-5,41%
Other operating expenses
1,67 მლრდ.
1,72 მლრდ.
152,80 მლნ.
1,68 მლრდ.
Net income
740,80 მლნ.
367,20 მლნ.
195,50 მლნ.
-241,20 მლნ.
Net profit margin
13,33%
6,74%
3,16%
-5,71%
Earnings per share
1,93
0,55
0,68
-0,63
Interest and investment income
-
-
27,30 მლნ.
-
Interest expense
-87,60 მლნ.
-91,10 მლნ.
-91,90 მლნ.
-67,40 მლნ.
Net interest expenses
-87,60 მლნ.
-91,10 მლნ.
-64,60 მლნ.
-67,40 მლნ.
Depreciation and amortization charges
440,20 მლნ.
469,40 მლნ.
512,30 მლნ.
495,40 მლნ.
EBITDA
1,23 მლრდ.
677,82 მლნ.
865,38 მლნ.
-15,48 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები